Emblicanin A

Metabolite details

Identifier

UEHSSTYZXFBDNL-UHFFFAOYSA-N

InChI Key

UEHSSTYZXFBDNL-UHFFFAOYSA-N

IUPAC name

[3,4,5,21,22,23-hexahydroxy-8,13,18-trioxo-12-(3,4,5-trihydroxybenzoyl)oxy-9,14,17-trioxatetracyclo[17.4.0.02,7.010,15]tricosa-1(23),2,4,6,11,19,21-heptaen-11-yl] 3,4,5-trihydroxybenzoate

Preferred name

Emblicanin A

INN name

—

Synonym

—

ChEBI

CHEBI:166663

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium

Observed in differential profiles

• G1_PBS_vs_G2_DSS
• wild_type_vs_patA_deletion